{
  "id" : "extension_bdg",
  "algorithm" : "eod_public",
  "version" : "1.0",
  "name" : "EOD Primary Tumor",
  "title" : "EOD Primary Tumor",
  "notes" : "**Note 1:** Code the tumor with the greatest extension when there are multiple simultaneous tumors.\n\n**Note 2:** Full eyelid thickness (code 300) is defined as including skin, orbicularis muscle, tarsus and conjunctiva (palpebral).",
  "footnotes" : "(1) Fritz AG, Ries LAG (eds). **SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998)**, National Cancer Institute, NIH Pub. No. 98-2313, Bethesda, MD, 1998\n\n(2) Young JL Jr, Roffers SD, Ries LAG, Fritz AG, Hurlbut AA (eds.). **SEER Summary Staging Manual-2000: Codes and Coding Instructions**, National Cancer Institute, NIH Pub. No. 01-4969, Bethesda, MD, 2001.\n\n(3) Collaborative Stage Work Group of the American Joint Committee on Cancer. **Collaborative Stage Data Collection System User Documentation and Coding Instructions, version 02.05**. American Joint Committee on Cancer (Chicago, IL)\n\n(4) Gress, D.M., Edge, S.B., Gershenwald, J.E., et al. **Principles of Cancer Staging**. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017: 3-30\n\n(5) Esmaeli, B., Finger, P.T., et al. **Eyelid Carcinoma**. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017: 779-785",
  "last_modified" : "2018-03-12T16:39:58.605Z",
  "definition" : [ {
    "key" : "eod_primary_tumor",
    "name" : "Code",
    "type" : "INPUT"
  }, {
    "key" : "description",
    "name" : "Description",
    "type" : "DESCRIPTION"
  }, {
    "key" : "eod_2018_t",
    "name" : "EOD 2018 T",
    "type" : "ENDPOINT"
  }, {
    "key" : "ss2018_t",
    "name" : "SS2018 T",
    "type" : "ENDPOINT"
  } ],
  "rows" : [ [ "000", "In situ, intraepidermal, intraepithelial, noninvasive\nBowen disease", "VALUE:Tis", "VALUE:IS" ], [ "100", "Lesion(s) confined to dermis\nMinimal infiltration of dermis\nSubcutaneous tissue (through entire dermis)\nUnderlying orbicularis muscle\n\nLocalized, NOS", "JUMP:tumor_size_with_primary_tumor_for_ajcc_t_80315", "VALUE:L" ], [ "200", "Eyelid margin\nTarsal plate\nTarsus", "JUMP:tumor_size_with_primary_tumor_for_ajcc_t_80315", "VALUE:L" ], [ "300", "Full eyelid thickness", "JUMP:tumor_size_with_primary_tumor_for_ajcc_t_80315", "VALUE:L" ], [ "400", "Bulbar conjunctiva\nIntraorbital structures, NOS\nOcular structures\nSclera\nSoft tissues of orbit", "VALUE:T4a", "VALUE:RE" ], [ "500", "Bone/periosteum of orbit\nBony walls of orbit (invades or evades through)\nLacrimal sac\nSkeletal muscle (except orbicularis muscle in eyelid)\nUnderlying cartilage", "VALUE:T4b", "VALUE:RE" ], [ "600", "Brain\nCentral nervous system (CNS)\nNasal cavity\nNasolacrimal duct\nOther craniofacial structures\nParanasal sinus\n\nFurther contiguous structures, NOS", "VALUE:T4b", "VALUE:D" ], [ "700", "Adjacent structure(s), NOS", "VALUE:T4", "VALUE:RE" ], [ "800", "No evidence of primary tumor", "VALUE:T0", "VALUE:U" ], [ "999", "Unknown; extension not stated\nPrimary tumor cannot be assessed\nNot documented in patient record\n\nDeath Certificate Only", "VALUE:TX", "VALUE:U" ] ]
}